Latin America attention deficit hyperactivity disorder (ADHD) therapeutics Industry is expected to reach USD 1.05 billion by 2020
Latin America Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market by Medication (Stimulants-Amphetamines, Non-Stimulants-Bupropion), Psychotherapy (Behavior Therapy, Cognitive Behavioral Therapy), and Education or Training
(EMAILWIRE.COM, August 28, 2017 ) Latin America attention deficit hyperactivity disorder (ADHD) Therapeutics Industry is expected to reach USD 1.05 billion by 2020 from USD 0.63 billion in 2015, growing at a CAGR of 10.90% during the forecast period 2015-2020.
Browse Full Report @ http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/
Attention deficit hyperactivity disorder (ADHD), is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children (above 12 years age) as compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for the ADHD is not clear but, expected to be resulted due to genetic factors and environmental influences. ADHD results in improper functioning of nervous system that led to attention deficit and hyperactivity/impulsiveness condition. ADHD is characterized by certain symptoms include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of attention deficit hyperactivity disorder (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants-atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/request-sample
Growing number of learning disability patients, rising number of treatment solutions, and government initiatives towards the adoption of innovative neurological disorders therapeutics are some of the major factors driving the growth of attention-deficit hyperactivity disorder (ADHD) therapeutics market in Latin America. However, low adoption of attention deficit hyperactivity disorder therapeutics and requirement of high cost to maintain longer medications for the treatment of ADHD are some of the factors restraining the growth of attention deficit hyperactivity disorder (ADHD) therapeutics market in Latin America.
Avail Discount @ http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/request-discount
Market Segmentation
• Treatment By Medication
o Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
o Non-Stimulants
Atomoxetine
Bupropion
Guanfacine
• Treatment By Psychotherapy
o Behavior Therapy
o Cognitive Behavioral Therapy
o Interpersonal Psychotherapy
o Family Therapy
• Treatment By Education or Training
o Parent Management Training
o Social Skills Training
School-Based Interventions On the basis of geographical areas, Latin America attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented as Brazil, Argentina, and Mexico.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308
The key players in attention deficit hyperactivity disorder (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Browse Full Report @ http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/
Attention deficit hyperactivity disorder (ADHD), is one of the most common neurological/psychiatric disorders among children and adolescents. ADHD is commonly observed in children (above 12 years age) as compared to adolescents. ADHD is also described as hyperkinetic disorder/ attention deficit disorder or neuropsychiatric disorder. The exact cause for the ADHD is not clear but, expected to be resulted due to genetic factors and environmental influences. ADHD results in improper functioning of nervous system that led to attention deficit and hyperactivity/impulsiveness condition. ADHD is characterized by certain symptoms include easy distraction & striving to maintain focus on one task, unable to remember things, impatience, and being continuously in motion, among others. The symptoms of attention deficit hyperactivity disorder (ADHD) are controlled by different modalities such as medication (stimulants-amphetamines; non-stimulants-atomoxetine), psychotherapy (behavior therapy, cognitive behavioral therapy), and education/training (parent management training, family training).
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/request-sample
Growing number of learning disability patients, rising number of treatment solutions, and government initiatives towards the adoption of innovative neurological disorders therapeutics are some of the major factors driving the growth of attention-deficit hyperactivity disorder (ADHD) therapeutics market in Latin America. However, low adoption of attention deficit hyperactivity disorder therapeutics and requirement of high cost to maintain longer medications for the treatment of ADHD are some of the factors restraining the growth of attention deficit hyperactivity disorder (ADHD) therapeutics market in Latin America.
Avail Discount @ http://www.marketdataforecast.com/market-reports/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308/request-discount
Market Segmentation
• Treatment By Medication
o Stimulants
Amphetamines
Methylphenidate
Dextroamphetamine
Dexmethylphenidate
o Non-Stimulants
Atomoxetine
Bupropion
Guanfacine
• Treatment By Psychotherapy
o Behavior Therapy
o Cognitive Behavioral Therapy
o Interpersonal Psychotherapy
o Family Therapy
• Treatment By Education or Training
o Parent Management Training
o Social Skills Training
School-Based Interventions On the basis of geographical areas, Latin America attention deficit hyperactivity disorder (ADHD) therapeutics market is segmented as Brazil, Argentina, and Mexico.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/latin-america-attention-deficit-hyperactivity-disorder-therapeutics-market-308
The key players in attention deficit hyperactivity disorder (ADHD) therapeutics market such as, Shire plc (Ireland), Neos Therapeutics, Inc. (U.S.), Eli Lilly and Company (U.S.), Pfizer Inc. (U.S.), Alcobra Ltd. (Israel), Supernus Pharmaceuticals, Inc. (U.S.), Noven Pharmaceuticals, Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson (U.S.), and Curemark, LLC. (U.S.).
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results